Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ellis

Showing results (171-180 of 252) with videos related to

Pageof 26
Sort By:
JACC. Cardiovascular Interventions|January 15, 2011
Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysisGhada W Mikhail, Robert T Gerber, David A Cox, et al.
Lancet (London, England)|September 6, 2003
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathyArman T Askari, Samuel Unzek, Zoran B Popovic, et al.
Journal of the American College of Cardiology|November 5, 2017
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB TrialsGregg W Stone, Alexandre Abizaid, Yoshinobu Onuma, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Long-term paclitaxel-eluting stent outcomes in elderly patientsDaniel E Forman, David A Cox, Stephen G Ellis, et al.
Journal of the American College of Cardiology|January 5, 2002
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stentingDeepak L Bhatt, Michel E Bertrand, Peter B Berger, et al.
Journal of the American College of Cardiology|April 20, 2005
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trialStephen G Ellis, Jeffrey J Popma, John M Lasala, et al.
Journal of the American College of Cardiology|February 2, 2002
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trialSorin J Brener, Uwe Zeymer, A A Jennifer Adgey, et al.
Journal of Cardiovascular Translational Research|March 8, 2012
Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trialSteven Rosenberg, Michael R Elashoff, Hsiao D Lieu, et al.
The Journal of Invasive Cardiology|October 3, 2014
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trialsRadoslaw Pracon, Maksymilian P Opolski, Gary S Mintz, et al.
The American Journal of Cardiology|October 22, 2008
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials)Jiro Aoki, Gary S Mintz, Neil J Weissman, et al.
Pageof 26

Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
JACC. Cardiovascular Interventions|January 15, 2011
Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysisGhada W Mikhail, Robert T Gerber, David A Cox, et al.
Lancet (London, England)|September 6, 2003
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathyArman T Askari, Samuel Unzek, Zoran B Popovic, et al.
Journal of the American College of Cardiology|November 5, 2017
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB TrialsGregg W Stone, Alexandre Abizaid, Yoshinobu Onuma, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Long-term paclitaxel-eluting stent outcomes in elderly patientsDaniel E Forman, David A Cox, Stephen G Ellis, et al.
Journal of the American College of Cardiology|January 5, 2002
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stentingDeepak L Bhatt, Michel E Bertrand, Peter B Berger, et al.
Journal of the American College of Cardiology|April 20, 2005
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trialStephen G Ellis, Jeffrey J Popma, John M Lasala, et al.
Journal of the American College of Cardiology|February 2, 2002
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trialSorin J Brener, Uwe Zeymer, A A Jennifer Adgey, et al.
Journal of Cardiovascular Translational Research|March 8, 2012
Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trialSteven Rosenberg, Michael R Elashoff, Hsiao D Lieu, et al.
The Journal of Invasive Cardiology|October 3, 2014
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trialsRadoslaw Pracon, Maksymilian P Opolski, Gary S Mintz, et al.
The American Journal of Cardiology|October 22, 2008
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials)Jiro Aoki, Gary S Mintz, Neil J Weissman, et al.
Pageof 26